We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Presepsin Concentrations Predicts Commensurate Decline in Kidney Function

By LabMedica International staff writers
Posted on 06 Jan 2020
Print article
Image: The PATHFAST system combines the accuracy of a full-scale laboratory analyzer with the flexibility of a mobile solution (Photo courtesy of LSI Medience Corporation)
Image: The PATHFAST system combines the accuracy of a full-scale laboratory analyzer with the flexibility of a mobile solution (Photo courtesy of LSI Medience Corporation)
Chronic kidney disease (CKD) is a worldwide health problem and its prevalence is rising, particularly in the elderly, mainly reflecting the increased life expectancy of the global population. Decrease in nephron number with aging leads to age-related decline in glomerular filtration rate (GFR).

The risk of developing sepsis increase with age and is higher in patients with CKD. Older patients are particularly susceptible to sepsis because of impaired physical function, comorbidity and hospitalization. The plasma presepsin concentrations of healthy individuals are very slight and have been shown to increase in response to bacterial infections according to disease severity.

Nephrologists at the Nippon Medical School Graduate School of Medicine (Tokyo, Japan) and their colleagues enrolled CKD patients aged ≥65 ye who had visited the nephrology a hospital outpatient department between April 2015 and March 2016. The study also included patients with CKD G5D, that is, stable patients with anuria receiving maintenance hemodialysis (HD), for at least one year at the dialysis unit of the hospital.

Blood samples from each patient were collected by venipuncture at the time of visit and complete blood count and routine biochemical parameters were measured using standard methods. Serum creatinine was measured in serum specimens using automated enzymatic method. Serum cystatin C was measured using a particle-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer (Siemens Healthcare Diagnostics, Erlangen Germany). C-reactive protein (CRP) was measured by latex-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer. Plasma presepsin concentrations were immediately measured using a Pathfast automated immunoassay analyzer (LSI Medience Corporation, Tokyo, Japan) based on noncompetitive chemiluminescent enzyme immunoassay.

The investigators examined plasma presepsin concentrations of 170 patients (101 men and 69 women and the age of patients ranged from 65 to 97 years, with a median age of 78 (72–85) years. There were 17 patients with CKD G5D (mean HD duration 146 ± 67 months). The mean estimated glomerular filtration rate was 51.8 ± 28.1 mL/min/1.73 m2. Plasma presepsin concentrations in those with CKD G4-G5 (362 pg/mL [273–553]) were significantly higher than in those with CKD G1-G2 (111 pg/mL [91–113]) and CKD G3 (145 pg/mL [124–205]). A high correlation between plasma presepsin concentrations and kidney function was observed.

The authors concluded that increases in plasma presepsin concentrations were exponentially correlated to decline in kidney function in the elderly with CKD and they developed a new prediction equation for plasma presepsin concentrations based on CKD-EPI eGFR Creatinine-Cystatin C equations (eGFRcr-cys). Prediction of plasma presepsin concentrations through commensurate decline in kidney function in the elderly should help in the precise diagnosis of sepsis in clinical practice. The study was published in the January 2020 issue of the journal Clinica Chimica Acta.

Related Links:
Nippon Medical School Graduate School of Medicine
Siemens Healthcare Diagnostics
LSI Medience Corporation


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Pipet Controller
Stripettor Pro

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.